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 ABSTRACT
Objectives: To describe the pharmacological characteristics of  medicines involved in administration errors and determine the frequency of
errors with potentially dangerous medicines and low therapeutic index, in clinical units of five teaching hospitals, in Brazil. Methods:
Multicentric study, descriptive and exploratory, using the non-participant observation technique (during the administration of  4958 doses
of medicines) and the anatomical therapeutic chemical classification (ATC). Results: Of that total, 1500 administration errors were
identified (30.3%). The administration of pharmacological groups - ATC (cardiovascular system, nervous system, alimentary tract and
metabolism system and anti-infectives for systemic use) showed a higher frequency of errors. In 13.0% of errors were involved potentially
dangerous medicines and in 12.2% medicines with low therapeutic index. Conclusion: The knowledge of the pharmacological profile could
be an important strategy to be used in the prevention medication errors in health institutions.
Keywords: Medication errors; Medication systems hospital
RESUMO
Objetivos: Descrever as características farmacológicas dos medicamentos envolvidos em erros de administração e determinar a frequência
desses erros com medicamentos potencialmente perigosos e de baixo índice terapêutico em unidades de clínica médica de cinco hospitais de
ensino brasileiros. Métodos: Estudo multicêntrico, descritivo/exploratório utilizando a técnica de observação não participante durante a
administração de 4958 doses de medicamentos e a classificação anatômica terapêutica química (ATC). Resultados:   Dentre esse total, foram
identificados 1500 erros de administração de medicamentos (30,3%). A administração dos fármacos dos grupos ATC - sistema cardiovascular,
sistema nervoso, trato alimentar e metabolismo e antinfecciosos de uso sistêmico apresentou maior frequência de erros. Em 13,0% dos erros
estavam envolvidos medicamentos potencialmente perigosos e em 12,2% medicamentos de baixo índice terapêutico. Conclusão: O conhecimento
do perfil farmacológico pode ser uma importante estratégia a ser utilizada na prevenção de erros de medicação em instituições de saúde.
Descritores: Erros de medicação; Sistemas de medicação no hospital
RESUMEN
Objetivos: Describir las características farmacológicas de los medicamentos envueltos en errores de administración y determinar la frecuencia
de esos errores en medicamentos potencialmente peligrosos y en los de bajo índice terapéutico, en unidades de clínica médica de cinco
hospitales de enseñanza brasileños. Métodos: Estudio multicéntrico, descriptivo-exploratorio utilizando la técnica de observación no
participante (durante la administración de 4.958 dosis de medicamentos) y la clasificación anatómica terapéutica química (ATC). Resultados:
Fueron identificados 1500 errores de administración de medicamentos (30,3%). La administración de los fármacos de los grupos ATC
(sistema cardiovascular, sistema nervioso, sistema digestivo y metabolismo, y, anti-infecciosos) de uso sistémico presentó mayor frecuencia de
errores. En 13,0% de los errores estaban envueltos medicamentos potencialmente peligrosos y en 12,2% medicamentos de bajo índice
terapéutico. Conclusión: El conocimiento del perfil farmacológico puede ser una importante estrategia para prevenir los errores de
medicación en las instituciones de salud.
Descriptores: Errores de medicación; Sistemas de medicación en hospital
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INTRODUCTION
The report “To Err is Human”, published by the Institute
of Medicine (IOM) in 2000, caused great repercussion in the
media and among health professionals, as it evoked the problem
of  adverse events in health services(1). Since then, patient and care
safety have become a source of concern in different countries(2).
The second IOM report, called “Crossing the Quality Chasm
a New Health System for the 21st Century”, was published in
2001 and stood out because it alerted health professionals to the
frequency of adverse events and the systemic nature of their
determining factors. Besides emphasizing the contribution of
adverse events to the increase in health costs and prevention as
an essential tool to expand patient safety, the report also
demonstrated that adverse drug event (ADE) are one of the
main reasons for patient damage(3).
Medication errors can be prevented, are related to the drugs
use process and can cause patient damage or not. ADE, on the
other hand, are characterized by the presence of damage, deriving
from an adverse reaction or medication error(4).
Hence, concerns with ADE are increasing, mainly after the
dissemination of epidemiological studies that estimate that each
patient hospitalized in North American hospitals is subject to
one medication error per day and that, every year, in hospitals, at
least 400,000 drugs-related avoidable adverse events occur in
hospitals(5).
Medication errors in the medication administration process
have been identified in Brazilian and international research. The
frequency of errors during the medication administration process
detected in these studies ranges from 14.9% to 59.5%(6-9). This
variation in administration error frequencies is due to differences
in the research methods used, in health service characteristics and
in the adopted error typology.
The range of  ADE for public health culminated in the IOM’s
most recent publication called “Preventing medication errors”,
which presents a series of recommendations to improve different
medication system processes(5). The recommendations address
strategic issues to increase the safety of medication use, covering
specific medication administration issues.
Medication errors are systemic and multiple determining
factors are involved. Among factors related to drugs contributing
to administration errors, the following stand out: the
administration route, required administration complexity,
pharmacological characteristics and the nursing team’s knowledge
on the drug(10-12).
In this context, this research aimed to describe the
pharmacological characteristics of drugs involved in
administration errors and to determine the frequency of these
errors involving high-alert medication (HAM) and narrow
therapeutic index drugs (NTID) at medical clinical units of five
Brazilian teaching hospitals.
METHODS
This multicenter exploratory research aimed to obtain detailed
information about the medication error variable in Brazilian
hospitals, with a view to determining the frequency and factors
associated with the occurrence of this event. Error was considered
as any discrepancy between what was prescribed and what the
nursing team administered to the patient. In this paper, data
about the pharmacological profile of the drugs involved in
administration errors are presented.
The research was developed at medical clinical units of five
Brazilian public teaching hospitals in the North, Northeast,
Southeast and Central-West of  Brazil. The medical clinical unit
was selected because it offers beds to patients with chronic-
degenerative diseases, who usually consume many drugs over
long period, covering different therapeutic classes.
For data collection, direct non-participant observation was
performed in accordance with an observation script. After a
twenty-hour training, fifteen research auxiliaries observed the
activities of nursing professionals responsible for drugs
administration during 30 days, including the three shifts (morning,
afternoon and night). Three research auxiliaries were designated
to each hospital and data were collected during the same period
at all research hospitals. The analysis unit was the administered
drug. Next, the data collected through observation were
confronted with the prescription to verify whether any discrepancy
occurred, considering patient, time, administration route, drug
and dosage. Patient safety experts validated the data collection
instrument and the observation script.
This research was carried out after authorization was obtained
from the research hospital boards and approval from the respective
Research Ethics Committees, according to protocols HCRP No
12216/2004, CEP/UNIFESP/HSP No 1413/04, CEPMHA/
HC/UFG No 096/04, Letter No 919-2004/GD and
FUNDHACRE Protocol No 174/2005. Before data collection,
the research subjects received clarifications about the study and
all participants signed the Free and Informed Consent Term.
Medication errors were classified according to the American
Society of Health System Pharmacists’ typology: dose error,
unauthorized drug error, route error, patient error and time
error(13). Time error was considered as the situation in which the
drug was administered more than 60 minutes before or after the
administration time defined on the prescription or administration
plan elaborated by the nurse or nursing technician.
The pharmacological classification was performed in
accordance with the anatomical therapeutic chemical (ATC)
system of the WHO Collaborating Centre for Drug Statistics
Methodology, an entity affiliated with the World Health
Organization(14).  NTID were identified in a tertiary
pharmacotherapy reference source and in the Brazilian Health
Surveillance Agency’s NTID list(15-16). HAM were classified
according to the Institute for Safe Medication Practice
(ISMP)(17).
The collected data were transferred to an EPIDATA 3.1
database. Database consistency was validated and checked through
double typing. SPSS 11.5 software was used for statistical analysis,
through univariate descriptive analysis with absolute and relative
frequencies.
RESULTS
In total, 4958 administered drugs doses were observed, and
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1500 errors were detected, that is, 30.3% of errors during
medication administration in this research. Error types were
distributed as follows: patient error (7 – 0.5%), route error (92 –
6.1%), unauthorized drug error (26 – 1.7%), dose error (215 –
14.4%) and time error (1160 – 77.3%).
Table 1 shows the distribution of  drug administration errors
according to pharmaceutical dosage form, most frequently
involving drugs for parenteral use (48.5%).
Table 1 – Drug administration errors, according to pharmaceutical
dosage form, at medical clinical units of public teaching hospitals,
Brazil, 2006
Table 3 – High - alert medication (HAM) involved in
administration errors at medical clinical units of public teaching
hospitals, Brazil, 2006
 
Pharmaceutical dosage Form N % 
For parenteral use  728 48.5 
Solid for oral use  626 41.8 
For inhalatory use 74 4.9 
Liquid for oral use 65 4.3 
For topical use 4 0.3 
For ophthalmic use 3 0.2 
Total 1500 100.0 
The ATC I classification evidences that group C (21.6%), N
(19.5%), A (19.1%) and J (18.5%) drugs were most involved in
errors, as shown in Table 2.
Table 2 - Drug administration errors, according to level I
anatomical therapeutic chemical (ATC) classification at medical
clinical units of public teaching hospitals, Brazil, 2006
 
Anatomical therapeutic chemical 
group 
N % 
C – Cardiovascular system  324 21.6 
N – Nervous system 292 19.5 
A – Alimentary tract and metabolism 287 19.1 
J – Anti-infectives for systemic use 277 18.5 
B – Blood and blood-forming organs 136 9.0 
R – Respiratory system 94 6.3 
H – Systemic hormonal preparations, 
excluding sex hormones and insulins 
64 4.3 
M – Musculo-skeletal system 8 0.6 
P – Antiparasitic products, insecticides 
and repellents 
8 0.6 
L – Antineoplastic and 
immunomodulating agents 
4 0.3 
S – Sensory organs 3 0.2 
G – Genito-urinary system and sex 
hormones 
2 0.1 
V – Various 1 0.1 
Total 1500 100.0 
The HAM identified in this research and the respective error
frequencies are presented in Table 3, corresponding to 13.0% of
drugs involved in administration errors.
NTID errors corresponded to 12.2% and heparin, vancomycin,
clindamycin, carbamazepine and phenitoin were the most
frequent drugs involved in administration errors (Table 4).
 
H igh- alert  medication N % 
Injectable heparin 65 33 .3 
Injectable tram adol  42 21 .4 
Injectable insulin 25 12 .7 
Injectable enoxaparin 11 5 .5 
Morphine tablet 11 5 .5 
Paracetam ol + codein tablet 10 5 .1 
T ram adol capsule 7 3 .6 
Injectable morphine 6 3 .1 
Metphormin tablet 4 2 .1 
Injectable potassium chloride 3 1 .5 
Warfarin tablet 3 1 .5 
Injectable glucose 50% 3 1 .5 
Injectable pethidine 2 1 .0 
Injectable sodium chloride  1 0 .4 
G libenclamide tablet 1 0 .4 
Injectable magnesium sulfate  1 0 .4 
T otal 195 100.0 
Table 4 – Narrow therapeutic index drugs (NTID) involved in
administration errors occurred in medical clinical units of public
teaching hospitals, Brazil, 2006
 
Narrow therapeutic index drugs N % 
Injectable heparin 65 35.5 
Injectable vancomycin  27 14.8 
Injectable clindamycin  24 13.1 
Carbamazepine tablet 13 7.1 
Injectable phenytoin  13 7.1 
Phenytoin tablet 9 4.9 
Clindamycin capsule 6 3.3 
Injectable aminophylline  5 2.8 
Injectable potassium chloride  3 1.7 
Injectable gentamicin  3 1.7 
Warfarin tablet 3 1.7 
Injectable amikacin  2 1.1 
Injectable amphotericin B  2 1.1 
Levothyroxine tablet 2 1.1 
Valproic acid capsule 1 0.5 
Clindamycin oral solution 1 0.5 
Clonidine tablet 1 0.5 
Injectable Phenobarbital  1 0.5 
Phenobarbital tablet 1 0.5 
Levodopa + carbidopa tablet 1 0.5 
Total 183 100.0 
DISCUSSION
The medication administration error frequency of 30.3%
found in this research can significantly contribute to knowledge
about the medication usage safety scenario in Brazilian hospitals.
These data related to hospitals from the North, Northeast,
Southeast and Central-West and the identified error percentage
is similar to international and Brazilian research(6-9). This result
reflects the need to improve medication systems in Brazilian
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hospitals, reconsidering subsystems, reducing steps and
simplifying processes with a view to decreasing medication
errors(18). This strategy is important because medication errors
should be addressed in a systemic perspective that permits
evidencing failures in different subsystems’ processes. This makes
it possible to put in practice improvements and decrease the
occurrence of these events. It should be highlighted though
that, in order to achieve effective results in intervention plans, it
is essential for prescription and administration processes to
receive special attention(10-11). Thus, the identification of drugs
and other factors associated with administration errors will also
contribute to the elaboration of action plans.
The distribution of medication errors in terms of
pharmaceutical dosage form evidences that drugs for parenteral
use, followed by oral use, were most frequently associated with
errors, in line with other studies(19-21). Due to its easy access and
commodity, the oral route is one of  the most used medication
administration routes, which explains the high incidence of errors
with drugs for oral administration(22).
Pharmaceutical dosage forms can be classified in terms of
administration complexity, risk of  damage and cost. Intravenous
infusion forms are considered the most complex, followed by
direct intravenous, intramuscular and subcutaneous
administration. Solid and liquid forms for oral use are the least
complex according to this classification. According to the
classification of risk for patient damage, parenteral forms present
more damage and are proportional to their complexity. Oral
usage forms, in function of the greater probability of absorption
and systemic action, rank third in terms of damage risk. The cost
ranking is the same proposed for administration complexity(22).
Hence, when establishing the therapeutic plan, prescribers need
to be encouraged to use less complex forms, with less damage
risk and lower costs, thus minimizing the possibility of errors.
The complexity of the parenteral drug administration process,
involving multiple steps, entails a greater need for adjustments
and monitoring during the administration process, consequently
increasing the risk of  errors(19-22). To expand medication
administration safety, particularly for parenteral drugs,
information technology applied to health should be incorporated
through intelligent infusion systems, bar codes, computerized
prescriptions and decision support programs(2).
The risk of errors involving oral solid drugs use is high due
to their large-scale use in hospitals, and increases when
administration through enteral feeding tubes is needed.
Medication errors in this condition can jeopardize treatment
efficacy and demand important multiprofessional actions to
improve the quality and safety of oral drugs administration in
patients receiving enteral feeding therapy(23). The pharmacist and
nurse should elaborate guidelines to guarantee adequate oral
solid drug use in this patient group, avoiding dispensation and
administration errors.
The analysis of the level I ATC classification shows that
drugs in groups C, N, A and J (Table 2) were the main therapeutic
groups related to errors. This result is equivalent to the profile
found by other researchers(12,24). The error frequency related to
cardiovascular drugs can be explained by the fact that they are
related with chronic illnesses, frequent at medical clinical units.
In this research, errors involving group J drugs, which include
antimicrobials and other anti-infectives, figured among the most
frequent errors. Concerns with medication errors involving
antimicrobials are growing in literature, as the inadequate use of
this therapeutic class contributes to the appearance of microbial
resistance(25). Therefore, under the nurse’s supervision, the
nursing team needs to be sensitized about this risk and pay
more attention to correct drug administration, especially with
regard to antimicrobials.
In order to supervise and carry out medication administration
activities, nurses need adequate knowledge about
pharmacodynamics, pharmacokinetics, administration techniques,
adverse drug reactions, drug interactions and therapeutic response
monitoring parameters(10-12,24). This knowledge is essential when
considering the variety of the therapeutic arsenal available in
hospitals, which increases day by day through the incorporation
of new therapeutic classes, new pharmaceutical dosage forms
and drugs release systems, generating a risk factor for medication
errors(12,20). Periodical professional recycling is a strategy that can
reduce the divergence between nursing professionals’ knowledge
and their activities in medication therapy practice(26).
This divergence mainly derives from the lack of pharmacology
education applied to care practice. Pharmacokinetics is taught in
undergraduate programs without any correlation with medication
errors and risks for patient safety. The same is true for the pattern
of adverse reactions, the intensity of the pharmacodynamic effect
and other relevant pharmacotherapy issues, mainly when
involving HAM.
According to the ISMP, although most drugs have a safe
therapeutic margin, some drugs inherently entail risks of patient
harm in case of errors in the use process. These drugs are called
HAM. These are no longer routine errors but, when they occur,
they are very severe and can lead to permanent injuries or be
lethal(17).
In this research, HAM errors corresponded to 13.0%, and
heparin was responsible for a majority (33.3%). Errors involving
tramadol, insulins and enoxaparin were also frequent. Heparin
figures among the ten drugs most frequently mentioned in error
notifications involving patient damage in the United States. In
2002, this drug was responsible for 9.5% of errors that causes
patient harm. Between 1999 and 2002 , rates varied between
4.5% and 5.5%, ranking first in severe error records(27).
 Due to the characteristics of HAM and the conditions in
which these drugs are used in hospitals, they are considered of
high risk as, when involved in errors, the consequences can be
severe. When putting in practice a medication error prevention
program, HAM should be one of the priority groups(17). HAM
are especially relevant in emergency services and intensive care
units, where their use is more frequent.
In medical clinical units, it is important to identify NTID
errors, a known risk factor for ADE. Errors involving these
drugs, particularly dose errors, can cause patient harm, turning
into a cause of hospital admission or extending hospitalization
time, mainly in pediatric and elderly age groups(26). The NTID
group is large, covering some HAM, some antimicrobials and
other drugs, many of which for oral use. These are drugs with a
very small difference between therapeutic and toxic concentration,
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demanding careful monitoring of dosage, clinical effects and,
sometimes, blood concentrations. The monitoring of blood
levels becomes very important for NTID, as the course and
intensity of pharmacological action are directly proportional to
the concentrations in body fluids.
Dose errors were the second most frequent category in this
research. These errors can be related to mistake in mathematical
calculations during drug preparations(11-12). In this research, dosage
errors are a source of concerning as, at medical clinical units, the
hospitalization of geriatric patients is frequent. This age group
presents decreased liver and kidney functions, besides decreased
metabolism and medication elimination(26).
The security margin for the use of NTID or HAM is small,
which is why dosage and time errors involving these types of
drugs are a source of concern. NTID can generate an error cascade
if  errors occur near the day of  therapeutic drug monitoring. As a
result of  a drugs error, the plasma level will not reflect the patient’s
clinical context, causing the physician to inadequately adjust the
dose, which can expose the patient to a new adverse event.
The main determining factors for the high incidence of time
errors are probably part of the administration process, such as the
nursing team’s time planning, which concentrates a large number
of  drugs in certain periods, generally in the morning. As a result,
the timing for drugs that require punctual administration, such as
antimicrobials and NTID, is not respected. This situation is generally
due to the high demand for activities and procedures at the
hospitalization unit during the morning shift. Another factor that
can lead to time errors is the inadequate functioning of the hospital
pharmacy’s drugs distribution system, leading to medication
delivery and, consequently, administration delays(20-21,28).
The relation between lack of knowledge and the medication
administration error problem is relevant. The administration
errors found in this research can partially be explained by this lack
of knowledge(24-26). There is an urgent need for actions to improve
nursing students’ pharmacology education and clinical nursing
professionals’ recycling.
In health services, the joint elaboration of  medication
administration manuals by the pharmaceutical and nursing team,
including objective pharmacotherapeutic information, has shown
to be an efficient strategy to increase medication usage safety(29).
CONCLUSION
This research presents a panorama of medication errors at
medical clinical units in five Brazilian public hospitals, indicating
the high error frequency related to drugs for parenteral
administration.
HAM and NTID errors identified in this research represent a
risk for medication use safety. Therefore, prevention measures
should be put in practice for these groups. Preventive actions
should be systemic though, covering the different medication
system processes. The application of systemic and planned
interventions can reduce the complexity of  the system and
improve the medication usage process, decreasing the number
of medication errors.
Expanding the availability of and access to medication
information in all medication system processes contributes to
improve medication use safety. Moreover, continuing and
permanent pharmacotherapy education is very valuable in
information and knowledge dissemination to health teams.
The optimization of the drugs administration process
significantly affects the reduction of medication errors and also
improves nursing care at the institution, directly influencing costs
and care quality.
Knowledge is one of the main tools health professionals
have at their disposal to guarantee safe and high-quality care to
patients. The researchers hope these results will support patient
safety plans and the elaboration of pharmacology training
programs integrated into health services and teaching institutions’
care practice.
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